All Posts
April 26, 2026
Patient's Guide: China's Top 10 Cardiac Surgery Hospitals (2023 Fudan Rankings)
China is a global leader in cardiac surgery. The 2023 Fudan Rankings identify the country's top cardiac surgery hospitals and their leading experts.
Read more →April 25, 2026
Beta-Thalassemia Major With No Suitable Transplant Donor: What Now?
Transfusion-dependent beta-thalassemia major is life-threatening. When every traditional transplant path is blocked, gene editing opens a cure using the patient's own cells.
Read more →April 24, 2026
How China's Toumai Robot Is Redefining the Limits of Remote Surgery
MicroPort's Toumai surgical robot is not just breaking distance records with a 12,000-km telesurgery, it is building a commercial closed loop for global remote surgery.
Read more →April 23, 2026
Unveiling Multiple Myeloma: From the Great Mimicker to a Controllable Chronic Disease
Multiple myeloma is misdiagnosed in up to 50% of cases. With BCMA/CD19 dual-target CAR-T therapy, average survival is now expected to reach 10 years or more.
Read more →April 22, 2026
When an Adult With Severe Thalassemia Is Deemed Too High-Risk for Transplant
Age and iron overload were once seen as absolute transplant contraindications. A Chinese team cured an 18-year-old thalassemia patient with haploidentical transplant.
Read more →April 21, 2026
MedTourChina x Healtra: Expanding Cross-Border Healthcare Collaboration
MedTourChina has signed a Framework Strategic Cooperation Agreement with Healtra, opening a new phase of China-GCC collaboration in knowledge exchange and healthcare innovation.
Read more →
April 20, 2026
Dual-Target CAR-T Therapy at Lu Daopei Hospital Revives a Critically Ill DLBCL Patient
A critically ill 60-year-old Egyptian DLBCL patient was treated with local radiotherapy combined with dual-target CD19/CD22 CAR-T cell therapy at Lu Daopei Hospital.
Read more →
April 19, 2026
Precise Targeting: Innovative Therapy Rewrites Cardiovascular Diagnosis and Treatment
Mr. Jiang's case at Shulan (Hangzhou) Hospital's Cardiology Department shows the progress of targeted drugs and MDT for hypertrophic obstructive cardiomyopathy.
Read more →
April 18, 2026
BCMA CAR-T Cell Therapy Achieves 100% ORR in Latest Clinical Study
A prospective study by the Lu Daopei Medical Team in Blood Advances reports that BCMA nanobody CAR-T therapy achieved 100% ORR in relapsed/refractory plasma cell neoplasms.
Read more →
April 17, 2026
Patient's Guide: China's Top 10 Rehabilitation Hospitals (2023 Fudan Rankings)
China's rehabilitation medicine leads in functional recovery, with the 2023 Fudan ranking of top rehabilitation hospitals and services for international patients.
Read more →
April 16, 2026
After Varian: No More Debate Over CT-Linac
An in-depth analysis of Varian's HyperSight and how it rewrites the definition of CT-Linac in cancer radiotherapy, bringing CBCT images up to diagnostic CT standards.
Read more →April 15, 2026
The Art of Fingertips Across 5,200 km: A Chinese Robot Clears Heart Arteries in Xinjiang from Shanghai
A world record: a 5,200 km remote coronary intervention using a robotic system developed in China. Shanghai doctors treat a Xinjiang patient with near-zero latency.
Read more →